IE0005711209
© BusinessWire
09.12.2025
ICLR
LISTED
NASDAQ
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused exclusively on trends in the rapidly growing Chinese biotech market. In total, both surveys captured...
Themefolio
Profiler
Peergroup
© BusinessWire
02.12.2025
ICLR
LISTED
NASDAQ
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup. The findings underscore the need for a site-centric, collaborative approach to overcome bottlenecks and enhance trial activation timelines.
The sur...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at the Jefferies London Healthcare Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that Mr. Barry Balfe, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 am GMT.
Any changes to this event and links to the live webcast (where available)...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
22.10.2025
ICLR
LISTED
NASDAQ
ICON Reports Third Quarter 2025 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the third quarter ended September 30, 2025.
CEO, Mr. Barry Balfe commented, “ICON’s results in quarter three were reflective of broad market conditions, as we continued to partner with customers to navigate an uncertain environment....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
24.09.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, October 22, 2025. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 23, 2025 at...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ICLR
LISTED
NASDAQ
ICON Announces CEO Transition
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the Board has appointed Mr. Barry Balfe, ICON’s Chief Operating Officer, to succeed Dr. Cutler as Chief Executive Officer effective 1 October 2025. Mr. Balfe...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ICLR
LISTED
NASDAQ
ICON plc to Participate at Upcoming Investor Conferences
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Barry Balfe, COO of ICON plc, will present at the Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 1:25 pm ET and Dr. Steve Cutler, CEO of ICON plc, will participate at the Deutsche Bank 20...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
ICLR
LISTED
NASDAQ
ICON Announces Results of Annual General Meeting
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 22, 2025 were duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders dated June 11, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
ICLR
LISTED
NASDAQ
ICON Reports Second Quarter 2025 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today reported its financial results for the second quarter ended June 30, 2025.
CEO, Dr. Steve Cutler commented, “ICON made solid progress in quarter two despite the continuing challenges within the clinical development and macro-economic...
Themefolio
Profiler
Peergroup
© BusinessWire
16.07.2025
ICLR
LISTED
NASDAQ
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clinical trials in a benchmarking report from the independent pharmaceutical market research company Industry Standard Research (ISR). ICON outpaced the a...
Themefolio
Profiler
Peergroup
© BusinessWire
07.07.2025
ICLR
LISTED
NASDAQ
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and sustainability, and as an employer...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025 after the market closes on Wednesday, July 23, 2025. The company will hold a conference call and webcast to discuss its financial results and performance...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
02.06.2025
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
27.05.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025 at 10.40 am CT.
Any changes to this event and links to the live webcast (where availab...
Themefolio
Profiler
Peergroup
© BusinessWire
19.05.2025
ICLR
LISTED
NASDAQ
ICON releases its ICON Cares 2024 Report
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering on its environmental, social and governance (ESG) goals, as delivered through its ICON Cares program.
In recognition of its efforts in 2024, ICON r...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
ICLR
LISTED
NASDAQ
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities.
Multi-indication studi...
Themefolio
Profiler
Peergroup
© BusinessWire
30.04.2025
ICLR
LISTED
NASDAQ
ICON Reports First Quarter 2025 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today reported its financial results for the first quarter ended March 31, 2025.
CEO, Dr. Steve Cutler commented, “ICON’s performance in quarter one was impacted by the volatility and cautiousness that continues to be present in the broader...
Themefolio
Profiler
Peergroup
© BusinessWire
09.04.2025
ICLR
LISTED
NASDAQ
Deadline Soon: ICON plc (ICLR) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 11, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and January 13, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© BusinessWire
09.04.2025
ICLR
LISTED
NASDAQ
ICON 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ICON plc - ICLR
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in securities class action lawsuits against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
ICLR
LISTED
NASDAQ
ICLR Deadline: Rosen Law Firm Urges ICON plc (NASDAQ: ICLR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024. ICON is a clinical research organization.
For more information, submit a form, email attorney Phillip Kim, or give us a call...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules First Quarter 2025 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025 after the market closes on Wednesday, April 30, 2025. The company will hold a conference call and webcast to discuss its financial results and performance...
Themefolio
Profiler
Peergroup
© BusinessWire
24.03.2025
ICLR
LISTED
NASDAQ
Kessler Topaz Meltzer & Check, LLP Reminds ICLR Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against ICON Public Limited Company (ICLR)
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff...
Themefolio
Profiler
Peergroup
© BusinessWire
05.03.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at Upcoming Investor Conferences
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners Global Healthcare Conference on Wednesday, March 12, 2025 at 8.00 am ET and at the Barclays 27th Annual Global Healthcare Conference on Thursday, Ma...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
ICLR
LISTED
NASDAQ
ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC (“ICON” or “the Company”) (NASDAQ: ICLR) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of...
Themefolio
Profiler
Peergroup
© BusinessWire
19.02.2025
ICLR
LISTED
NASDAQ
ICON Reports Fourth Quarter and Full Year 2024 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the fourth quarter and full year ended December 31, 2024.
CEO, Dr. Steve Cutler commented, “ICON’s results in quarter four were in-line with our expectations as we continue to manage through a challenging t...
Themefolio
Profiler
Peergroup
© BusinessWire
17.02.2025
ICLR
LISTED
NASDAQ
ICLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), t...
Themefolio
Profiler
Peergroup
© BusinessWire
16.02.2025
ICLR
LISTED
NASDAQ
ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC (“ICON” or “the Company”) (NASDAQ: ICLR) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ICLR
LISTED
NASDAQ
Kessler Topaz Meltzer & Check, LLP Class Action Announcement ICLR: A Securities Fraud Class Action Lawsuit Was Filed Against ICON Public Limited Company (ICLR)
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff...
Themefolio
Profiler
Peergroup
© BusinessWire
14.02.2025
ICLR
LISTED
NASDAQ
Deadline Alert: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”)....
Themefolio
Profiler
Peergroup
© PR Newswire
14.02.2025
ICLR
LISTED
NASDAQ
Contact Levi & Korsinsky by April 11, 2025 Deadline to Join Class Action Against ICON Public Limited Company(ICLR)
News Preview
NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seek...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ICLR
LISTED
NASDAQ
Deadline Approaching: ICON plc (ICLR) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR WHO SU...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
ICLR
LISTED
NASDAQ
ICON INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-007...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON investors have until April 11, 2025 to file a lead plaintiff motion.
IF YOU S...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages ICON plc (ICLR) Investors to Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“Icon” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages ICON plc (ICLR) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON investors have until April 11, 2025 to file a lead plaintiff motion.
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
ICLR
LISTED
NASDAQ
ICON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ICON plc - ICLR
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
ICLR
LISTED
NASDAQ
Rosen Law Firm Urges ICON plc (NASDAQ: ICLR) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). ICON is a clinical research organization.
For more information, submit a form, email attorney Philli...
Themefolio
Profiler
Peergroup
© BusinessWire
30.01.2025
ICLR
LISTED
NASDAQ
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI) tools that deliver efficiencies across the clinical trial process, including study startup, document management, resource forecasting and metrics reporting.
ICO...
Themefolio
Profiler
Peergroup
© BusinessWire
29.01.2025
ICLR
LISTED
NASDAQ
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year 2024 results after the market closes on Wednesday, February 19, 2025. The company will hold a conference call and webcast to discuss its financial results a...
Themefolio
Profiler
Peergroup
© BusinessWire
14.01.2025
ICLR
LISTED
NASDAQ
ICON Issues Financial Guidance for Full Year 2025
News Preview
ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025. For the full year 2025, revenue is expected to be in the range of $8,050 - $8,650 million, representing growth of approximately 1% at the midpoint and adjusted ea...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2025
ICLR
LISTED
NASDAQ
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals developing treatments for neurodegenerative disorders. The findings indicate that, despite recent successes in developing disease modifying treatments for A...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2025
ICLR
LISTED
NASDAQ
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 3.45pm PST.
Any changes to this event and links to the live webcast will be posted on the In...
Themefolio
Profiler
Peergroup
© BusinessWire
23.12.2024
ICLR
LISTED
NASDAQ
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024.
On TIME Magazine’s 2024 list of World’s Best Companies ICON was ranked as the highest clinical research organisation out of 1,000 companies for the second year in a row, and in it...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
ICLR
LISTED
NASDAQ
ICON Announces Appointment of Chief Operating Officer
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Barry Balfe as Chief Operating Officer (COO).
Barry is a long-tenured ICON employee with over 20 years of service and brings extensive leadership experience and capability to the role of COO. He has held a numbe...
Themefolio
Profiler
Peergroup
© BusinessWire
05.12.2024
ICLR
LISTED
NASDAQ
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent global survey of 101 biotech and pharma professionals across Europe and North America to understand the trajectory of AI and digital innovation adoption within clinical research.
Respondents revealed t...
Themefolio
Profiler
Peergroup
© BusinessWire
27.11.2024
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Icon investments or would like...
Themefolio
Profiler
Peergroup
© BusinessWire
26.11.2024
ICLR
LISTED
NASDAQ
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of federal securities laws.
On October 23, 2024, Icon released its third quarter 2024 financial results, missing consensus estimates “due to specific c...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
ICLR
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On October 23, 2024, Icon released its thir...
Themefolio
Profiler
Peergroup
© BusinessWire
15.11.2024
ICLR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Ico...
Themefolio
Profiler
Peergroup
© BusinessWire
15.11.2024
ICLR
LISTED
NASDAQ
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of federal securities laws.
On October 23, 2024, Icon released its third quarter 2024 financial results, missing consensus estimates “due to specific cu...
Themefolio
Profiler
Peergroup
© BusinessWire
15.11.2024
ICLR
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
News Preview
The Law Offices of Frank R. Cruz announces an investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On October 23, 2024, Icon released its third...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2024
ICLR
LISTED
NASDAQ
ICON plc to Present at the Jefferies London Healthcare Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:00am GMT.
Any changes to this event and links to the live...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
ICLR
LISTED
NASDAQ
ICON Reports Third Quarter 2024 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the third quarter ended September 30, 2024.
CEO, Dr. Steve Cutler commented, “ICON’s results for the third quarter did not meet the expectations we had previously provided due to specific customer and divis...
Themefolio
Profiler
Peergroup
© BusinessWire
27.09.2024
ICLR
LISTED
NASDAQ
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the third quarter 2024 after the market closes on Wednesday, October 23, 2024. The company will hold a conference call and webcast to discuss its financial results and performance on Th...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2024
ICLR
LISTED
NASDAQ
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent survey of over 100 professionals engaged in oncology drug development to understand the current state of emerging oncology treatment development, including the associated clinical trial dynamics. Respond...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2024
ICLR
LISTED
NASDAQ
ICON plc to Present at the Baird 2024 Global Healthcare Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, 2024 at 3:45 pm ET.
Any changes to this event and links to the live webcast will be posted on the Invest...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2024
ICLR
LISTED
NASDAQ
ICON Announces Appointment of New Chief Financial Officer
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO).
Nigel brings extensive experience and capability to the role of CFO. He commenced his career with KPMG, before joining Elan Corporation where he held a num...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
